About this Calculator

The Ketorolac Dose Calculator is a clinical support tool designed to help healthcare professionals determine the appropriate parenteral (IV/IM) and oral (PO) dosing of ketorolac tromethamine, a potent non-steroidal anti-inflammatory drug (NSAID). It provides patient-specific recommendations by considering critical factors such as age, body weight, and renal function, aligning with established clinical guidelines to promote safe and effective administration for short-term pain management.

Outputs Explained

Upon entering the patient's data, the calculator provides a clear set of dosing recommendations:

  • Recommended Dose: The appropriate single dose (e.g., 15 mg or 30 mg for IV/IM).
  • Dosing Interval: The recommended frequency of administration (e.g., every 6 hours).
  • Maximum Daily Dose: The total amount of ketorolac that should not be exceeded in a 24-hour period (e.g., 60 mg or 120 mg).
  • Dosing Rationale: An explanation of whether a standard or reduced dose was selected based on the patient's age, weight, or renal function status.
  • Calculated CrCl: If serum creatinine is provided, the tool displays the calculated creatinine clearance used for dose determination.

How to Use the Tool

To use the calculator effectively, follow these steps:

  1. Enter Patient Age: Input the patient's age in years.
  2. Enter Patient Weight: Input the patient's body weight and select the appropriate unit (kg or lbs).
  3. Select Biological Sex: Choose the patient's sex, which is used to improve the accuracy of the creatinine clearance calculation.
  4. Choose Route of Administration: Select the intended route from Intravenous (IV), Intramuscular (IM), or Oral (PO).
  5. Provide Renal Function: You can either have the tool calculate creatinine clearance by entering the patient's serum creatinine (SCr) level or directly input a known CrCl value.

Dosing Overview

Ketorolac dosing is stratified to minimize risks, especially in vulnerable populations. The calculator applies the following logic:

  • Standard Parenteral Dose (IV/IM): 30 mg every 6 hours, with a maximum daily dose of 120 mg. This is for patients under 65 years of age, weighing at least 50 kg, and with normal renal function (CrCl ≥ 50 mL/min).
  • Reduced Parenteral Dose (IV/IM): 15 mg every 6 hours, with a maximum daily dose of 60 mg. This dose is recommended for patients who meet one or more of the following criteria:
    • Age ≥ 65 years
    • Body weight < 50 kg (110 lbs)
    • Moderately impaired renal function (CrCl < 50 mL/min)
  • Oral Dose (PO): 10 mg every 4 to 6 hours, with a maximum daily dose of 40 mg. The initial oral dose after switching from parenteral therapy is 20 mg.

Switching Between Formulations

Oral ketorolac is indicated only as continuation therapy following an initial course of IV or IM administration. When switching, ensure the total combined duration of treatment for all formulations does not exceed 5 days. Careful coordination is required to transition from parenteral to oral dosing without exceeding the maximum daily dose limits.

Missed Dose Information

Ketorolac is typically administered on an as-needed (PRN) basis for pain, not on a strict, fixed schedule. The primary focus should be on not exceeding the recommended single dose and the maximum total daily dose. If a patient is on a scheduled regimen and misses a dose, they should take it as soon as they remember, unless it is nearly time for the next scheduled dose. Patients should be instructed never to take a double dose to make up for a missed one.

Safety Alerts

CRITICAL DURATION LIMIT: The total combined duration of therapy with ketorolac (IV, IM, and PO) must not exceed 5 days. Longer use significantly increases the risk of severe gastrointestinal bleeding, cardiovascular events, and renal injury.
Black Box Warnings: Ketorolac carries significant risks, including serious gastrointestinal bleeding, ulceration, and perforation; increased risk of serious cardiovascular thrombotic events (myocardial infarction and stroke); and contraindication for peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. It is also contraindicated in patients with advanced renal impairment (CrCl < 30 mL/min).

Frequently Asked Questions

Why is the maximum duration of ketorolac limited to 5 days?
The risk of serious adverse events, particularly severe gastrointestinal bleeding and kidney damage, increases significantly with treatment duration beyond 5 days. This limit is a critical safety measure mandated by regulatory agencies.

What happens if I use the calculator for a patient under 17 years old?
The calculator will indicate that ketorolac is contraindicated. The safety and efficacy of ketorolac have not been established in the pediatric population (patients under 17 years of age).

Why does the calculator require biological sex?
Biological sex is a variable in the Cockcroft-Gault equation, which is used to estimate creatinine clearance. Female patients typically have lower muscle mass, and the formula includes an adjustment factor (0.85) to account for this, providing a more accurate renal function estimate.

Which patients qualify for a reduced parenteral dose?
A reduced dose (15 mg IV/IM) is recommended for patients who are elderly (≥ 65 years), have a low body weight (< 50 kg), or have moderate renal impairment. These factors increase the risk of drug accumulation and adverse effects.

Can I use this calculator for patients with severe kidney disease?
No. The calculator will show a contraindication if the calculated or entered creatinine clearance is less than 30 mL/min, as ketorolac is contraindicated in patients with advanced renal impairment due to the risk of worsening kidney function.

Why is oral ketorolac only for continuation therapy?
Oral ketorolac has a slower onset of action and is less potent than the parenteral formulation. It is intended for managing pain after it has been initially controlled with IV or IM ketorolac, not for initiating therapy for acute, severe pain.

Does this calculator account for liver impairment?
No, the calculator does not adjust for hepatic impairment. Ketorolac should be used with caution in patients with impaired liver function, and it is contraindicated in those with active or advanced liver disease. Clinical judgment is required.

What weight is used for the creatinine clearance calculation?
The tool uses the provided patient weight in kilograms to calculate creatinine clearance via the Cockcroft-Gault equation. It automatically converts pounds to kilograms if lbs are selected.

References

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators